Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia

International Journal of Infectious Diseases

Volumn 29, Issue , 2014, Pages e197-e199

  Dumke, Roger ^a   Stolz, Simone ^b   Jacobs, Enno ^a   Juretzek, Thomas ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b CARL THIEM KLINIKUM   (Germany)

Author keywords

Community acquired pneumonia; Mycoplasma pneumoniae; Typing Macrolide resistance

Indexed keywords

AZITHROMYCIN; CEFUROXIME AXETIL; MACROLIDE; RIBOSOME RNA; SULTAMICILLIN; TOBRAMYCIN; ANTIINFECTIVE AGENT; RNA 23S;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; CASE REPORT; GENOTYPE; HUMAN; INFECTION; MALE; MIXED INFECTION; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; PHENOTYPE; SEPSIS; DRUG EFFECTS; GENETICS; MICROBIOLOGY; MUTATION; PNEUMONIA, MYCOPLASMA;

ADOLESCENT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DRUG RESISTANCE, BACTERIAL; HUMANS; MALE; MUTATION; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; RNA, RIBOSOMAL, 23S;

EID: 84911130778     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.07.014     Document Type: Article

References (4)

1. Atkinson T.P., Waites K.B. Mycoplasma pneumoniae infections in childhood. Pediatr Infect Dis J 2014, 33:92-94.
2. Principi N., Esposito S. Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection. J Antimicrob Chemother 2013, 68:506-511.
3. Nilsson A.C., Jensen J.S., Björkman P., Persson K. Development of macrolide resistance in Mycoplasma pneumoniae-infected Swedish patients treated with macrolides. Scand J Infect Dis 2014, 46:315-319.
4. Averbuch D., Hidalgo-Grass C., Moses A.E., Engelhard D., Nir-Paz R. Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010. Emerg Infect Dis 2011, 17:1079-1082.